Search CORE

1,175 research outputs found

PMD16 Implication of Preventing Disease on Life Years Gained (LYG)

Author: Caro JJ
Klittich WS
Publication venue: International Society for Pharmacoeconomics and Outcomes Research (ISPOR). Published by Elsevier Inc.
Publication date: 31/05/1998
Field of study

Elsevier - Publisher Connector

MM6 Decision Analysis: What is Its Utility for Pharmacoeconomic Analysis?

Author: Caro JJ
Migliaccio-Walle K
Publication venue: International Society for Pharmacoeconomics and Outcomes Research (ISPOR). Published by Elsevier Inc.
Publication date: 31/05/1998
Field of study

Elsevier - Publisher Connector

PCV75 DERIVING COST INPUT VALUES FOR USE IN A MARKOV MODEL FOR EXPLORING THE CLINICAL CONSEQUENCES OF RIMONABANT IN ADDITION TO DIET AND EXERCISE IN OVERWEIGHT OR OBESE SUBJECTS

Author: Caro JJ
McEwan P
Nicholls C
Publication venue: International Society for Pharmacoeconomics and Outcomes Research (ISPOR). Published by Elsevier Inc.
Publication date: 31/12/2006
Field of study

Elsevier - Publisher Connector

PMH1 The Economic Burden of Schizophrenia: Acute General Hospital Costs

Author: Caro JJ
O'Brien JA
Pietrusewicz MJ
Shomphe LA
Publication venue: International Society for Pharmacoeconomics and Outcomes Research (ISPOR). Published by Elsevier Inc.
Publication date: 31/05/1998
Field of study

Elsevier - Publisher Connector

PCV8 Readiness to Comply And Outcomes of Antihypertensive Therapy

Author: Caro JJ
Garfield FB
Redding C
Stafford J
Willey C
Publication venue: International Society for Pharmacoeconomics and Outcomes Research (ISPOR). Published by Elsevier Inc.
Publication date: 31/05/1998
Field of study

Elsevier - Publisher Connector

POB4 USE OF GROWTH CURVE ANALYSES FOR DISCRETE EVENT SIMULATION: A CASE STUDY OF POOLED CLINICAL TRIALS OF THE EFFECTS OF RIMONABANT ON CARDIOMETABOLIC RISK FACTORS IN OBESE PATIENTS

Author: Caro JJ
Getsios D
Ishak KJ
Lavaud V
Moller J
Publication venue: International Society for Pharmacoeconomics and Outcomes Research (ISPOR). Published by Elsevier Inc.
Publication date: 30/06/2006
Field of study

Elsevier - Publisher Connector

W2: ESTIMATING DRUG EFFECTS: FROM CLINICAL TRIAL RESULTS TO ACTUAL PRACTICE

Author: Caro JJ
Coniglio A
Migliaccio-Walle K
Thizon de Gaulle I
Publication venue: International Society for Pharmacoeconomics and Outcomes Research (ISPOR). Published by Elsevier Inc.
Publication date: 31/01/1999
Field of study

Elsevier - Publisher Connector

PDB50 MODELLING THE CLINICAL CONSEQUENCES OF RIMONABANT IN ADDITION TO DIET AND EXERCISE IN ABDOMINALLY OBESE PATIENTS WITH TYPE-2 DIABETES

Author: Annemans L
Caro JJ
Lamotte M
Lavaud V
McEwan P
Nicholls C
Publication venue: 'Elsevier BV'
Publication date: 31/12/2005
Field of study

Elsevier - Publisher Connector

ES5 RIMONABANT FOR THE TREATMENT OF OVERWEIGHT AND OBESE INDIVIDUALS AT INCREASED CARDIOMETABOLIC RISK:AN ECONOMIC EVALUATION USING DISCRETE EVENT SIMULATION

Author: Caro JJ
Danel A
Getsios D
Ishak KJ
McEwan P
Moller J
Publication venue: International Society for Pharmacoeconomics and Outcomes Research (ISPOR). Published by Elsevier Inc.
Publication date: 31/12/2006
Field of study

Elsevier - Publisher Connector

PUK3 DITROPAN XL PROVIDES SUPERIOR OUTCOMES AND LOWER COSTS COMPARED TO DETROL LA

Author: Caro JJ
Dubois D
Duchesne I
El-Hadi W
Feng W
Getsios D
Publication venue: International Society for Pharmacoeconomics and Outcomes Research (ISPOR). Published by Elsevier Inc.
Publication date: 30/06/2004
Field of study

Elsevier - Publisher Connector

…

core

core